BioCryst Pharmaceuticals Aktie

Kaufen
Verkaufen
7,04 EUR -0,18 EUR -2,44 %
7,57 USD +0,18 USD +2,44 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 1,5 Mrd. EUR

Div. Rendite 0,00%

WKN 896047

ISIN US09058V1035

Symbol BCRX


BioCryst Pharmaceuticals Aktie Analyse

22.06.18 BioCryst Pharmaceuticals Neutral Seaport Global Securities
20.12.17 BioCryst Pharmaceuticals Equal weight Barclays Capital
15.09.17 BioCryst Pharmaceuticals Sector Perform RBC Capital Markets
12.11.07 BioCryst Pharmaceuticals average Caris & Company, Inc.
20.09.07 BioCryst Pharmaceuticals average Caris & Company, Inc.
29.08.07 BioCryst Pharmaceuticals halten Jaindl & Mautz
20.06.07 BioCryst Pharmaceuticals average Caris & Company
29.03.07 BioCryst Pharmaceuticals market perform CE Unterberg, Towbin
19.02.07 BioCryst Pharmaceuticals neutral Jaindl & Mautz
11.12.06 BioCryst Pharmaceuticals Average Caris & Company
14.11.06 BioCryst Pharmaceuticals halten Jaindl & Mautz
11.10.06 BioCryst Pharmaceuticals halten Jaindl & Mautz
28.04.06 BioCryst Pharmaceuticals Market Perform CE Unterberg, Towbin
20.04.06 BioCryst Pharmaceuticals Caris & Company
27.10.05 BioCryst Pharmaceuticals Market Perform Rodman & Renshaw